Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. J Clin Oncol. 2021 07 20; 39(21):2375-2385.

View in: PubMed

subject areas

Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Disease-Free Survival
Female
Humans
Middle Aged
Neoplasm Staging
Paclitaxel
Trastuzumab

authors with profiles

Rita Nanda